Journal Article

Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study

Turan, Guluzar Arzu, Sivrikoz, Oya Nermin, Tatar, Sumeyra, Gur, Esra Bahar, Cengiz, Hakan, Adakan, Saban, Yilmaz, Osman, Eskicioglu, Fatma, Sahin, Nur

2015

Overview

Purpose To evaluate the efficacy of myo-inositol (MI) pretreatment in OHSS. Methods In this experimental OHSS rat model, 42 immature Wistar albino female rats were divided into 6 groups: (1) the control group, (2) the ovarian stimulation group, (3) the OHSS group, (4) the OHSS + Metformin group, (5) OHSS + MI group, (6) OHSS + Metformin + MI group. OHSS was established after treatment with metformin and myo-inositol for 14 days, in the meanwhile the treatment of metformin and myo-inositol was also continued. All animals were killed 48 h after hCG administration and were compared in terms of vascular permeability, ovarian weight and diameter, ovarian VEGF, COX-2 and PEDF expression (immunohistochemistry), serum PEDF and estradiol (E2) levels. Results Vascular permeability, VEGF and COX-2 expressions were reduced in animals treated with MI and/or metformin. While PEDF expression was increased in the groups taking metformin, there was no difference in PEDF expression in the group taking MI and OHSS group. There was no significant difference in serum PEDF levels between groups. Blood E2 levels were decreased in groups treated with MI or metformin compared to the OHSS group. Conclusions Our data demonstrate that myo-inositol is effective in preventing OHSS, similar to metformin. Although the two drugs are thought to act through distinct mechanisms, there is no apparent benefit to co-treatment with both drugs in an animal model of OHSS. Administration of myo-inositol prior to IVF treatment may favor the control of ovulation induction. Further studies are necessary to elucidate the mechanism of action and further support our findings.

• Publisher: Springer Berlin Heidelberg,Springer Nature B.V
• Subject: Animals / Antidiabetics / Cyclooxygenase 1 - metabolism / Disease Models, Animal / Endocrinology / Estradiol - therapeutic use / Female / Gynecologic Endocrinology and Reproductive Medicine / Gynecology / Human Genetics / Inositol - therapeutic use / Medicine / Medicine & Public Health / Membrane Proteins - metabolism / Obstetrics/Perinatology/Midwifery / Ovarian Hyperstimulation Syndrome - prevention & control / Ovulation Induction / Permeability / Rats / Rats, Wistar / Vascular Endothelial Growth Factor A - metabolism / Vitamin B Complex - therapeutic use